Try our business solution for free!

Chronic hepatitis B therapeutic sales share among 8 major markets

Published by Statista Research Department, Jan 1, 2016
This statistic shows the comparison of the share of hepatitis B therapeutic sales among eight major markets in 2014 and 2024. China's share among the global eight major markets for chronic hepatitis B therapeutics was some 39 percent in 2014, and it is predicted to increase to over 47 percent in 2024.

Share of chronic hepatitis B therapeutic sales among 8 major markets in 2014 and 2024

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2016

Region

Worldwide

Survey time period

as of January 2016

Supplementary notes

All data is based on primary research interviews and surveys conducted with KOLs and high-prescribing physicians in the countries included in this report.
* Forecast

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Top pharmaceutical drugs "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Top pharmaceutical drugs

Global overview

4

Top companies' top products

5

Best-selling drugs

8

U.S. overview

4

Outlook

5

Further related statistics

12

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in ChinaCoronavirus COVID-19 in ChinaPharmaceutical industry in JapanVaccine industry in ChinaPharmaceuticals in India
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu